OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders, today announced the close of an oversubscribed $67 million Series B financing.
Cognitive Credit, the global leader in data and analytics software for corporate credit markets, today announces that it has closed its latest funding round in 2Q24, a $10mm Series B raise led by ETFS Capital, with existing investor XTX Ventures also participating.
You.com has raised a $50M Series B led by Georgian, with participation from Salesforce Ventures, NVIDIA, SBVA (formerly Softbank Ventures Asia), DuckDuckGo, Day One Ventures, and others, bringing our total funding to $99 million. Series B Funding will enable us to continue building the most trusted AI productivity engine and expand into the enterprise.
Butlr, a physical AI (PAI) startup, announced $38M in Series B funding to meet the increasing demand for its sensors and anonymous data that can be used in any building to better understand how humans interact in a space. This results in more collaborative, energy efficient and safer buildings where people work and live.
Siepe LLC, a trusted provider of software and technology-enabled services for private credit and CLO managers, has raised $30 million in a Series B funding round led by WestCap, a strategic operating and investing firm with $6 billion in assets under management (AUM).
Opkey has built an AI platform to help organizations continuously test finance, HR and other enterprise resource planning (ERP) software. Now, on the back of some strong customer traction — more than 200 large enterprise customers; partnerships with system integrators like KMPG and PwC — it’s closed a Series B of $47 million.
Honolulu, HI-based Onebrief, the leading software platform for military staff workflows and collaboration, has secured a Series B funding round, bringing the company’s total capital raised to $53 million led by Human Capital, with participation from 9Yards Capital and Caffeinated Capital.
XII Medical, Inc., a clinical-stage medical technology company developing innovative therapies for obstructive sleep apnea, has raised $45 million Series B equity financing led by Omega Funds and joined by new investor Intuitive Ventures.
PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for new, morphology-driven disease analysis, has raised $20.7 million in Series B funding, bringing its total funding to $31.5 million led by Eventide Asset Management, with other participants in include Labcorp, Quest Diagnostics, and GenHenn Capital Venture, along with existing investors.
Eppo, the cutting-edge experimentation platform, has raised $28 million series B financing, led by Davis Treybig at Innovation Endeavors with participation from Preeti Rathi at Icon Ventures with additional support from existing investors Menlo Ventures and Amplify Partners.
